Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,000 | 3 | 92.6% |
| Food and Beverage | $4,028 | 166 | 6.4% |
| Education | $629.85 | 7 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $58,009 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $989.70 | 28 | $0 (2023) |
| ABBVIE INC. | $689.57 | 39 | $0 (2024) |
| Solta Medical, a division of Bausch Health US, LLC | $551.26 | 3 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $372.71 | 16 | $0 (2023) |
| Qiagen, LLC | $247.98 | 2 | $0 (2019) |
| Lilly USA, LLC | $212.85 | 7 | $0 (2023) |
| GENZYME CORPORATION | $197.10 | 10 | $0 (2022) |
| Galderma Laboratories, L.P. | $144.69 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $122.13 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,631 | 7 | Dermavant Sciences, Inc. ($30,500) |
| 2023 | $28,565 | 26 | Dermavant Sciences, Inc. ($27,509) |
| 2022 | $882.27 | 44 | Sun Pharmaceutical Industries Inc. ($215.35) |
| 2021 | $841.78 | 41 | Janssen Biotech, Inc. ($209.44) |
| 2020 | $312.74 | 14 | Janssen Biotech, Inc. ($86.14) |
| 2019 | $779.51 | 20 | Qiagen, LLC ($247.98) |
| 2018 | $429.66 | 16 | Janssen Biotech, Inc. ($112.84) |
| 2017 | $216.31 | 8 | Janssen Biotech, Inc. ($117.17) |
All Payment Transactions
176 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/26/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: ACNE | ||||||
| 11/19/2024 | Organogenesis Inc. | NUSHIELD (Medical Supply) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: WOUND CARE | ||||||
| 08/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $31.17 | General |
| 07/03/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $27,500.00 | General |
| Category: DERMATOLOGY | ||||||
| 05/02/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $32.53 | General |
| 01/04/2024 | Dermavant Sciences, Inc. | TAPINAROF (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Consulting Fee | Cash or cash equivalent | $27,500.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: DERMATOLOGY | ||||||
| 11/03/2023 | Solta Medical, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $514.48 | General |
| 10/10/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Dermatology | ||||||
| 09/26/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Dermatology | ||||||
| 08/22/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Immunology | ||||||
| 08/09/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/09/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: DERMATOLOGY | ||||||
| 07/28/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Dermatology | ||||||
| 07/25/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.28 | General |
| Category: Dermatology | ||||||
| 07/17/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/13/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Dermatology | ||||||
| 04/25/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: DERMATOLOGY | ||||||
| 04/21/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Dermatology | ||||||
| 04/07/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Dermatology | ||||||
| 03/24/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 248 | 402 | $37,587 | $18,228 |
| 2022 | 9 | 475 | 735 | $70,722 | $36,986 |
| 2021 | 8 | 225 | 337 | $30,897 | $16,732 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 101 | $10,100 | $6,361 | 63.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 35 | 40 | $6,040 | $2,993 | 49.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $6,750 | $2,788 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 24 | $3,552 | $2,186 | 61.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 35 | 50 | $5,600 | $1,755 | 31.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 24 | 27 | $4,050 | $1,596 | 39.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 21 | 115 | $1,495 | $548.69 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 202 | $20,200 | $12,577 | 62.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 73 | 101 | $15,251 | $8,100 | 53.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 67 | 67 | $10,050 | $5,263 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 34 | $5,032 | $3,254 | 64.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 59 | 79 | $8,848 | $3,067 | 34.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 32 | 35 | $5,250 | $1,932 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 27 | $1,620 | $993.49 | 61.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 23 | 23 | $2,300 | $987.76 | 42.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 37 | 167 | $2,171 | $812.72 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 88 | $8,800 | $6,149 | 69.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 25 | 32 | $4,832 | $2,727 | 56.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $5,550 | $2,296 | 41.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 21 | 21 | $3,150 | $1,756 | 55.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 26 | 37 | $4,144 | $1,495 | 36.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 27 | $1,620 | $1,158 | 71.5% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 18 | 18 | $1,800 | $756.13 | 42.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 22 | 77 | $1,001 | $396.63 | 39.6% |
About Fatima Fahs
Fatima Fahs is a Dermatology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1942659958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fatima Fahs has received a total of $62,658 in payments from pharmaceutical and medical device companies, with $30,631 received in 2024. These payments were reported across 176 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($58,000).
As a Medicare-enrolled provider, Fahs has provided services to 948 Medicare beneficiaries, totaling 1,474 services with total Medicare billing of $71,946. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Southfield, MI
- Active Since 06/09/2016
- Last Updated 09/22/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1942659958
Products in Payments
- TAPINAROF (Drug) $30,500
- VTAMA (Drug) $27,509
- TREMFYA (Drug) $602.25
- DUPIXENT (Biological) $324.43
- Humira (Biological) $264.84
- MDX QUANTIFERON (Device) $247.98
- Winlevi (Drug) $240.32
- Tremfya (Drug) $219.97
- TALTZ (Drug) $212.85
- SKYRIZI (Biological) $168.28
- RINVOQ (Biological) $153.06
- COSENTYX (Biological) $112.95
- EUCRISA (Drug) $109.37
- Otezla (Drug) $106.09
- STELARA (Biological) $99.99
- CELLEX/XTS PHOTOPHERESIS SYSTEM (Device) $99.06
- ILUMYA (Biological) $86.70
- REMICADE (Biological) $67.49
- ADBRY (Biological) $67.12
- HUMIRA (Biological) $58.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Southfield
Dr. Robert Singer, Md, MD
Dermatology — Payments: $15,328
Dr. Ross Brothers, M.d, M.D
Dermatology — Payments: $9,881
Dr. Emily Levin, Md, MD
Dermatology — Payments: $8,475
Dr. Bobbi Edwards, Md, MD
Dermatology — Payments: $5,930
Dr. Steven Shumer, Md, MD
Dermatology — Payments: $3,147
Paige Norwick
Dermatology — Payments: $2,167